The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBiome Tech Regulatory News (BIOM)

Share Price Information for Biome Tech (BIOM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 77.50
Bid: 70.00
Ask: 85.00
Change: 0.00 (0.00%)
Spread: 15.00 (21.429%)
Open: 77.50
High: 77.50
Low: 77.50
Prev. Close: 77.50
BIOM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Proposed issue of shares to directors and dealings

2 May 2018 15:27

RNS Number : 9325M
Biome Technologies PLC
02 May 2018
 

 

Prior to its publication, the information contained within this announcement was deemed by the Company to constitute inside information as stipulated under Article 7 of the Market Abuse Regulation (EU) No. 596/2014 ("MAR"). In addition, market soundings (as defined in MAR) were taken in respect of the Proposed Share Issue and the Proposed Share Sale (as defined below) with the result that certain persons became aware of inside information, as permitted by MAR. With the publication of this announcement, this information is now considered to be in the public domain and those persons who received inside information in a market sounding are no longer in possession of such inside information relating to the Company and its securities.

 

 

2 May 2018

Biome Technologies plc

 ("Biome", "the Company" or "the Group")

 

Proposed issue of shares to directors and PDMR dealings

 

 

The Company announces that, subsequent to the AGM and approval of the 2017 annual report, its executive directors, Paul Mines and Declan Brown, have elected to take their bonus entitlement for 2017 in shares instead of cash and have committed not to sell these shares for a period of at least 12 months (other than to settle tax liabilities directly associated with this issue of shares).

 

Following the completion of the issue of shares (the "Proposed Share Issue") and a sale to settle tax liabilities (the "Proposed Share Sale") it is intended that Paul Mines will increase his holding of ordinary shares in the Company by 4,640 ordinary shares and will hold 26,525 ordinary shares in the Company, representing 1.12% of the Company's enlarged ordinary issued share capital.

 

Following the completion of the Proposed Share Issue and the Proposed Share Sale, Declan Brown will increase his holding of ordinary shares in the Company by 3,262 ordinary shares and will hold 3,970 ordinary shares in the Company, representing 0.17% of the Company's enlarged ordinary share capital.

 

The details of the proposed transactions are as follows:

 

· Under the Proposed Share Issue it is intended that Paul Mines, Chief Executive Officer, will be issued 9,192 ordinary shares and Declan Brown, Group Finance Director, will be issued 6,460 ordinary shares.

· Under the Proposed Share Sale, in order to settle tax liabilities that will be directly associated with the Proposed Share Issue, Paul Mines intends to sell 4,552 ordinary shares and Declan Brown intends to sell 3,198 ordinary shares.

 

Application has been made to the London Stock Exchange for admission of the 15,652 new ordinary shares ("Admission") and, subject to issue and allotment of these shares, dealings on AIM are expected to occur on or around 4 May 2018. Following the issue and allotment of these shares the total issued share capital and total voting rights of the Company will be 2,363,188 ordinary shares with voting rights.

 

 

-Ends-

 

 

 

 

 

For further information please contact: Biome Technologies plc

 

Paul Mines, Chief Executive Officer

Declan Brown, Group Finance Director

www.biometechnologiesplc.com

Tel: +44 (0) 2380 867 100

 

Allenby Capital

David Hart/Alex Brearley (Nominated Adviser)

Kelly Gardiner (Broker)

www.allenbycapital.com

Tel: +44 (0) 20 3328 5656

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHUGUAPAUPRGCP
Date   Source Headline
16th Oct 20063:17 pmRNSNotifiable Interest
12th Oct 200612:35 pmRNSDoc re. Posting of Prospectus
11th Oct 20061:09 pmRNSNotifiable Interest
9th Oct 200611:13 amRNSProposed Placing & Open Offer
5th Oct 200610:25 amRNSFinancing Update
3rd Oct 200612:56 pmRNSStatement re. Press Comment
2nd Oct 20064:41 pmRNSSecond Price Monitoring Extn
2nd Oct 20064:35 pmRNSPrice Monitoring Extension
8th Sep 20067:01 amRNSTrading Statement
17th Aug 20067:44 amRNSTrading Statement
16th Aug 20065:52 pmRNSAdditional Listing - AMEND
14th Aug 200611:55 amRNSAdditional Listing
10th Aug 200612:25 pmRNSRe Contract
14th Jul 20067:56 amRNSInterim Results - Replacement
14th Jul 20067:00 amRNSInterim Results
2nd Jun 200611:26 amRNSNew Ord Share Placing-Amendmt
2nd Jun 20068:45 amRNSNew Ordinary Share Placing
25th May 20067:02 amRNSWrap 100 FDA approval
16th May 200610:43 amRNSAdditional Listing
15th May 20067:01 amRNSAppointment of Adviser
3rd May 20061:05 pmRNSNotifiable Interest
2nd May 20064:58 pmRNSResult of AGM
2nd May 20062:00 pmRNSAGM Statement
10th Apr 20063:12 pmRNSAnnual Report and Accounts
7th Apr 20062:46 pmRNSAdditional Listing
13th Mar 20067:02 amRNSDirectorate Change
28th Feb 20067:02 amRNSPreliminary Results
24th Feb 20067:02 amRNSCooperation with Wal-Mart
14th Feb 20069:07 amRNSAdditional Listing
14th Feb 20067:00 amRNSUS FDA approval for Starpol
9th Feb 200610:42 amRNSIsraCaps new licence terms
9th Feb 20067:02 amRNSRe: BioProgress plc
16th Dec 20057:01 amRNSFunding for R&D facility
16th Dec 20057:01 amRNSPre Close Update
14th Dec 20057:01 amRNSLandmark deal with Perseco
8th Dec 200510:25 amRNSShare Listing Application
30th Nov 20055:40 pmRNSDirectorate Change
28th Nov 20059:24 amRNSBoard Changes
8th Nov 20057:01 amRNSPatent sale process update
3rd Nov 20054:47 pmRNSExercise of Options
1st Nov 20057:02 amRNSChange of Adviser
12th Oct 20057:00 amRNSApproval of Starpol
3rd Oct 20057:00 amRNSPatent Disposal & Update
22nd Sep 20057:02 amRNSRe Agreement
12th Sep 20057:03 amRNSDevelopment of capsule
5th Sep 20057:03 amRNSRe: Completion
30th Aug 20053:30 pmRNSDoc re. Result of EGM
30th Aug 200511:08 amRNSEGM Statement
30th Aug 20057:03 amRNSRe Agreement
5th Aug 200511:15 amRNSRe posting of circular

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.